These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9360581)

  • 1. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight.
    Haley EC; Lewandowski C; Tilley BC
    Ann Emerg Med; 1997 Nov; 30(5):676-82. PubMed ID: 9360581
    [No Abstract]   [Full Text] [Related]  

  • 2. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients.
    Grotta J
    N Engl J Med; 1997 Oct; 337(18):1310-3. PubMed ID: 9345085
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial.
    Tanne D; Levine SR; Brey RL; Lin H; Tilley BC;
    Neurology; 2003 Oct; 61(8):1158-9. PubMed ID: 14581697
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
    Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for stroke.
    Brott T
    Arch Neurol; 1996 Dec; 53(12):1305-6. PubMed ID: 8970461
    [No Abstract]   [Full Text] [Related]  

  • 6. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.
    Caplan LR; Mohr JP; Kistler JP; Koroshetz W
    N Engl J Med; 1997 Oct; 337(18):1309-10; discussion 1313. PubMed ID: 9345084
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid resorption of intraventricular hemorrhage after thrombolytic therapy of ischemic stroke.
    Szabo K; Sommer A; Gass A; Hennerici M
    Cerebrovasc Dis; 2001 Aug; 12(2):144. PubMed ID: 11490110
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A; Yang Y; Nakada MT; Li Q; Yang T
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
    Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
    Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview: hyperacute rt-PA stroke treatment. The NINDS rt-PA Stroke Study Group.
    Donnarumma R; Kongable G; Barch C; Braimah J; Bratina P; Daley S; Rapp K; Sailor S; Spilker J
    J Neurosci Nurs; 1997 Dec; 29(6):351-5. PubMed ID: 9479655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-type plasminogen activator should not be used in acute ischemic stroke.
    Riggs JE
    Arch Neurol; 1996 Dec; 53(12):1306-8. PubMed ID: 8970462
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.
    Grotta J;
    Cerebrovasc Dis; 2001; 12(3):258-63. PubMed ID: 11641593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with intravenous rt-PA in a general hospital context: A review of the Saint-Jean Hospital experience from Perpignan, France].
    Sablot D; Cassarini JF; Akouz A; Benejean JM; Leibinger F; Faillie X; Vidry E; Ayrignac X; Castro S; Sinaya L; Bertrand JL; Garcia Y; Arnoud B; Negre C
    Rev Neurol (Paris); 2006 Nov; 162(11):1109-17. PubMed ID: 17086147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemopericardium and cardiac tamponade after thrombolysis for acute ischemic stroke.
    Kasner SE; Villar-Cordova CE; Tong D; Grotta JC
    Neurology; 1998 Jun; 50(6):1857-9. PubMed ID: 9633741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. t-PA in acute ischemic stroke.
    Ben Zemenick R
    Ann Emerg Med; 1998 Jun; 31(6):792-3. PubMed ID: 9624329
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolysis in acute ischemic stroke.
    Luisi A; Hume AL
    J Am Board Fam Pract; 1998; 11(2):145-51. PubMed ID: 9542706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability?
    Wyer PC; Osborn HH
    Ann Emerg Med; 1997 Nov; 30(5):629-38. PubMed ID: 9360575
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial.
    Tilley BC; Marler J; Geller NL; Lu M; Legler J; Brott T; Lyden P; Grotta J
    Stroke; 1996 Nov; 27(11):2136-42. PubMed ID: 8898828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.